TransMedics to Present at Upcoming March Investor Conferences

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

TransMedics (Nasdaq: TMDX) management will present at two investor conferences in March 2026: a fireside chat at the TD Cowen 46th Annual Health Care Conference on March 2, 2026 at 1:50 p.m. EST, and a virtual presentation at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 16, 2026 at 10:00 a.m. EST.

A live and archived webcast and the company's standard investor presentation will be available on the Investors section of the TransMedics website.

Argus Feb 18 session

+1.26% close to close 1.1x rel. volume Open Argus

Details

News Market Reaction – TMDX

On Feb 18, the first trading day after this news, TMDX closed 1.26% above the previous close.

Data tracked by StockTitan Argus for the Feb 18 session.

Key Figures

TD Cowen conference number: 46th Annual Oppenheimer conference number: 36th Annual TD Cowen date: March 2, 2026 +4 more

TD Cowen conference number: 46th Annual; TD Cowen 46th Annual Health Care Conference
Oppenheimer conference number: 36th Annual; Oppenheimer 36th Annual Healthcare MedTech & Services Conference
TD Cowen date: March 2, 2026; TD Cowen 46th Annual Health Care Conference date
TD Cowen time: 1:50 p.m. EST; Scheduled fireside chat time at TD Cowen conference
Oppenheimer date: March 16, 2026; Oppenheimer 36th Annual Healthcare MedTech & Services Conference date
Oppenheimer time: 10:00 a.m. EST; Scheduled virtual presentation time at Oppenheimer conference
Number of conferences: 2; Total investor conferences mentioned in the release

Historical Context

5 past events · Latest: Feb 10

5 events

Feb 10
Earnings timing

24h Move

-4.3%

Announcement of date and time for Q4 and full-year 2025 results.
Feb 09
Regulatory approval

24h Move

+0.9%

Full and unconditional FDA IDE approval for ENHANCE Heart trial.
Jan 12
HQ expansion

24h Move

-1.8%

New global headquarters lease and campus expansion in Somerville.
Dec 30
Conference appearance

24h Move

-0.2%

Planned presentation at the 44th Annual J.P. Morgan Healthcare Conference.
Dec 24
Equity grants

24h Move

-2.2%

Inducement stock options and RSUs granted to five new employees.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

02/17/2026 - 04:05 PM EST

ANDOVER, Mass., Feb. 17, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in two upcoming investor conferences. TransMedics management is scheduled to participate in a fireside chat at the TD Cowen 46^th Annual Health Care Conference in Boston on Monday, March 2, 2026, at 1:50 p.m. EST and virtually at the Oppenheimer 36^th Annual Healthcare MedTech & Services Conference on Monday, March 16, 2026, at 10:00 a.m. EST.

Event: TD Cowen 46^th Annual Health Care Conference
Date: Monday, March 2, 2026
Time: 1:50 p.m. EST

Event: Oppenheimer 36^th Annual Healthcare MedTech & Services Conference
Date: Monday, March 16, 2026
Time: 10:00 a.m. EST

A live and archived webcast of the presentations will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-upcoming-march-investor-conferences-302689917.html

SOURCE TransMedics Group, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will TransMedics (TMDX) present at the TD Cowen conference and how can I watch it?

TransMedics will present at TD Cowen on March 2, 2026 at 1:50 p.m. EST. According to the company, a live and archived webcast will be available on the Investors section of the TransMedics website, where the standard investor presentation is also posted.

What time is TransMedics (TMDX) scheduled to speak at the Oppenheimer Healthcare MedTech conference?

TransMedics is scheduled to present virtually at Oppenheimer on March 16, 2026 at 10:00 a.m. EST. According to the company, the session will be webcast live and archived on the Investors section of the TransMedics website.

Will TransMedics (TMDX) provide a replay of the March 2026 investor presentations?

Yes, TransMedics will provide an archived replay of both presentations. According to the company, the live and archived webcasts will be posted on the Investors section of the TransMedics website after each event.

What topics will TransMedics (TMDX) management cover in the March 2026 fireside chat?

The company announced management will participate in a fireside chat but did not list specific topics. According to the company, the session will follow the TD Cowen conference format and the investor presentation is available online.

Where can investors find TransMedics (TMDX) presentation materials for March 2026 events?

Investors can access presentation materials on the company's Investors website. According to the company, the standard investor presentation and live/archived webcasts for both March events are available at investors.transmedics.com.

Are TransMedics (TMDX) presentations in March 2026 in-person or virtual?

The TD Cowen fireside chat is in-person in Boston; the Oppenheimer presentation is virtual. According to the company, the TD Cowen session is March 2, 2026 at 1:50 p.m. EST and Oppenheimer is March 16, 2026 at 10:00 a.m. EST.

TransMedics to Present at Upcoming March Investor Conferences